Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells

Jennifer L. Gilmore, Jeffrey A. Scott, Zhor Bouizar, Alexander Robling, Sarah E. Pitfield, David J. Riese, John Foley

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Parathyroid hormone-related protein (PTHrP) is an autocrine/paracrine factor produced by breast cancer cells that is speculated to play a major role in permitting breast cancer cells to grow into the bone microenvironment by stimulating the bone resorption axis. It has been previously shown that EGFR signaling induces the production of PTHrP in several primary and transformed epithelial cell types. Therefore, we investigated the relationship between EGFR and PTHrP gene expression in human breast cancer cells. Of a panel of 7 breast epithelial and cancer cell lines, the osteolytic, EGFR- positive lines (MDA-MB-231 and NS2T2A1) exhibited higher levels of PTHrP transcript expression. Amphiregulin mRNA levels in all lines were approximately 2 orders of magnitude higher than those of TGFα or HB-EGF. In the EGFR bearing lines, the receptor was phosphorylated at tyrosine 992 under basal conditions, and the addition of 100 nM amphiregulin did not lead to the phosphorylation of other tyrosine residues typically phosphorylated by the prototypical ligand EGF. Treatment of the EGFR positive lines with the EGFR inhibitor PD153035 and amphiregulin-neutralizing antibodies reduced PTHrP mRNA levels by 50-70%. Stable EGFR expression in the MCF7 line failed to increase basal PTHrP mRNA levels; however, treatment of this cell line with exogenous EGF or amphiregulin increased PTHrP transcription 3-fold. Transient transfection analysis suggests that the MAPK pathway and ETS transcription factors mediate EGFR coupling to PTHrP gene expression. Taken together, it appears that autocrine stimulation of EGFR signaling by amphiregulin is coupled to PTHrP gene expression via EGFR Tyr992 and MAPK, and that this pathway may contribute to PTHrP expression by breast tumor cells.

Original languageEnglish
Pages (from-to)493-505
Number of pages13
JournalBreast Cancer Research and Treatment
Volume110
Issue number3
DOIs
StatePublished - Aug 2008

Fingerprint

Parathyroid Hormone-Related Protein
Breast Neoplasms
Gene Expression
Epidermal Growth Factor
Messenger RNA
Tyrosine
Epithelial Cells
Amphiregulin
Cell Line
Bone Resorption
Neutralizing Antibodies
Transfection
Transcription Factors
Phosphorylation
Ligands

Keywords

  • Amphiregulin
  • Breast cancer
  • Epidermal growth factor receptor (EGFR)
  • Parathyroid hormone-related peptide (PTHrP)

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. / Gilmore, Jennifer L.; Scott, Jeffrey A.; Bouizar, Zhor; Robling, Alexander; Pitfield, Sarah E.; Riese, David J.; Foley, John.

In: Breast Cancer Research and Treatment, Vol. 110, No. 3, 08.2008, p. 493-505.

Research output: Contribution to journalArticle

Gilmore, Jennifer L. ; Scott, Jeffrey A. ; Bouizar, Zhor ; Robling, Alexander ; Pitfield, Sarah E. ; Riese, David J. ; Foley, John. / Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. In: Breast Cancer Research and Treatment. 2008 ; Vol. 110, No. 3. pp. 493-505.
@article{e34c1cc1293444e49b24709a617e04ec,
title = "Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells",
abstract = "Parathyroid hormone-related protein (PTHrP) is an autocrine/paracrine factor produced by breast cancer cells that is speculated to play a major role in permitting breast cancer cells to grow into the bone microenvironment by stimulating the bone resorption axis. It has been previously shown that EGFR signaling induces the production of PTHrP in several primary and transformed epithelial cell types. Therefore, we investigated the relationship between EGFR and PTHrP gene expression in human breast cancer cells. Of a panel of 7 breast epithelial and cancer cell lines, the osteolytic, EGFR- positive lines (MDA-MB-231 and NS2T2A1) exhibited higher levels of PTHrP transcript expression. Amphiregulin mRNA levels in all lines were approximately 2 orders of magnitude higher than those of TGFα or HB-EGF. In the EGFR bearing lines, the receptor was phosphorylated at tyrosine 992 under basal conditions, and the addition of 100 nM amphiregulin did not lead to the phosphorylation of other tyrosine residues typically phosphorylated by the prototypical ligand EGF. Treatment of the EGFR positive lines with the EGFR inhibitor PD153035 and amphiregulin-neutralizing antibodies reduced PTHrP mRNA levels by 50-70{\%}. Stable EGFR expression in the MCF7 line failed to increase basal PTHrP mRNA levels; however, treatment of this cell line with exogenous EGF or amphiregulin increased PTHrP transcription 3-fold. Transient transfection analysis suggests that the MAPK pathway and ETS transcription factors mediate EGFR coupling to PTHrP gene expression. Taken together, it appears that autocrine stimulation of EGFR signaling by amphiregulin is coupled to PTHrP gene expression via EGFR Tyr992 and MAPK, and that this pathway may contribute to PTHrP expression by breast tumor cells.",
keywords = "Amphiregulin, Breast cancer, Epidermal growth factor receptor (EGFR), Parathyroid hormone-related peptide (PTHrP)",
author = "Gilmore, {Jennifer L.} and Scott, {Jeffrey A.} and Zhor Bouizar and Alexander Robling and Pitfield, {Sarah E.} and Riese, {David J.} and John Foley",
year = "2008",
month = "8",
doi = "10.1007/s10549-007-9748-8",
language = "English",
volume = "110",
pages = "493--505",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells

AU - Gilmore, Jennifer L.

AU - Scott, Jeffrey A.

AU - Bouizar, Zhor

AU - Robling, Alexander

AU - Pitfield, Sarah E.

AU - Riese, David J.

AU - Foley, John

PY - 2008/8

Y1 - 2008/8

N2 - Parathyroid hormone-related protein (PTHrP) is an autocrine/paracrine factor produced by breast cancer cells that is speculated to play a major role in permitting breast cancer cells to grow into the bone microenvironment by stimulating the bone resorption axis. It has been previously shown that EGFR signaling induces the production of PTHrP in several primary and transformed epithelial cell types. Therefore, we investigated the relationship between EGFR and PTHrP gene expression in human breast cancer cells. Of a panel of 7 breast epithelial and cancer cell lines, the osteolytic, EGFR- positive lines (MDA-MB-231 and NS2T2A1) exhibited higher levels of PTHrP transcript expression. Amphiregulin mRNA levels in all lines were approximately 2 orders of magnitude higher than those of TGFα or HB-EGF. In the EGFR bearing lines, the receptor was phosphorylated at tyrosine 992 under basal conditions, and the addition of 100 nM amphiregulin did not lead to the phosphorylation of other tyrosine residues typically phosphorylated by the prototypical ligand EGF. Treatment of the EGFR positive lines with the EGFR inhibitor PD153035 and amphiregulin-neutralizing antibodies reduced PTHrP mRNA levels by 50-70%. Stable EGFR expression in the MCF7 line failed to increase basal PTHrP mRNA levels; however, treatment of this cell line with exogenous EGF or amphiregulin increased PTHrP transcription 3-fold. Transient transfection analysis suggests that the MAPK pathway and ETS transcription factors mediate EGFR coupling to PTHrP gene expression. Taken together, it appears that autocrine stimulation of EGFR signaling by amphiregulin is coupled to PTHrP gene expression via EGFR Tyr992 and MAPK, and that this pathway may contribute to PTHrP expression by breast tumor cells.

AB - Parathyroid hormone-related protein (PTHrP) is an autocrine/paracrine factor produced by breast cancer cells that is speculated to play a major role in permitting breast cancer cells to grow into the bone microenvironment by stimulating the bone resorption axis. It has been previously shown that EGFR signaling induces the production of PTHrP in several primary and transformed epithelial cell types. Therefore, we investigated the relationship between EGFR and PTHrP gene expression in human breast cancer cells. Of a panel of 7 breast epithelial and cancer cell lines, the osteolytic, EGFR- positive lines (MDA-MB-231 and NS2T2A1) exhibited higher levels of PTHrP transcript expression. Amphiregulin mRNA levels in all lines were approximately 2 orders of magnitude higher than those of TGFα or HB-EGF. In the EGFR bearing lines, the receptor was phosphorylated at tyrosine 992 under basal conditions, and the addition of 100 nM amphiregulin did not lead to the phosphorylation of other tyrosine residues typically phosphorylated by the prototypical ligand EGF. Treatment of the EGFR positive lines with the EGFR inhibitor PD153035 and amphiregulin-neutralizing antibodies reduced PTHrP mRNA levels by 50-70%. Stable EGFR expression in the MCF7 line failed to increase basal PTHrP mRNA levels; however, treatment of this cell line with exogenous EGF or amphiregulin increased PTHrP transcription 3-fold. Transient transfection analysis suggests that the MAPK pathway and ETS transcription factors mediate EGFR coupling to PTHrP gene expression. Taken together, it appears that autocrine stimulation of EGFR signaling by amphiregulin is coupled to PTHrP gene expression via EGFR Tyr992 and MAPK, and that this pathway may contribute to PTHrP expression by breast tumor cells.

KW - Amphiregulin

KW - Breast cancer

KW - Epidermal growth factor receptor (EGFR)

KW - Parathyroid hormone-related peptide (PTHrP)

UR - http://www.scopus.com/inward/record.url?scp=46949099486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46949099486&partnerID=8YFLogxK

U2 - 10.1007/s10549-007-9748-8

DO - 10.1007/s10549-007-9748-8

M3 - Article

VL - 110

SP - 493

EP - 505

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -